Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine

Saved in:
Bibliographic Details
Published inNeurology Vol. 91; no. 17; p. 797
Main Authors Moreno, Gabriel M, Gandhi, Rhea, Lessig, Stephanie L, Wright, Brenton, Litvan, Irene, Nahab, Fatta B
Format Journal Article
LanguageEnglish
Published United States 23.10.2018
Subjects
Aged
Aged, 80 and over
Antipsychotic Agents - therapeutic use
Female
Humans
Male
Middle Aged
Parkinson Disease - complications
Parkinson Disease - mortality
Piperidines - therapeutic use
Psychotic Disorders - drug therapy
Psychotic Disorders - etiology
Psychotic Disorders - mortality
Quetiapine Fumarate - therapeutic use
Retrospective Studies
Survival Analysis
Treatment Outcome
Urea - analogs & derivatives
Urea - therapeutic use
Online AccessGet more information

Cover

More Information
ISSN:1526-632X
DOI:10.1212/WNL.0000000000006396